• 1. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 2. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aniline and substituted anilines

Recent Advances in the Study of {4-(5-Methyl-4H-1,2,4-triazol-3-yl)methylphenyl}amine Dihydrochloride (CAS: 1185543-38-7)

The compound {4-(5-Methyl-4H-1,2,4-triazol-3-yl)methylphenyl}amine Dihydrochloride (CAS: 1185543-38-7) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications. This research briefing aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential clinical applications.

Recent studies have highlighted the role of this compound as a key intermediate in the synthesis of novel kinase inhibitors. Kinases are critical targets in the treatment of various cancers and inflammatory diseases, and the structural features of {4-(5-Methyl-4H-1,2,4-triazol-3-yl)methylphenyl}amine Dihydrochloride make it a promising candidate for further development. Researchers have employed advanced computational modeling and high-throughput screening techniques to elucidate its binding affinity and selectivity towards specific kinase targets.

In addition to its role in kinase inhibition, this compound has also been investigated for its potential as a modulator of cellular signaling pathways. A study published in the Journal of Medicinal Chemistry demonstrated its efficacy in modulating the activity of key signaling molecules involved in apoptosis and cell proliferation. These findings suggest that {4-(5-Methyl-4H-1,2,4-triazol-3-yl)methylphenyl}amine Dihydrochloride could serve as a valuable tool for understanding the molecular mechanisms underlying these processes.

Another area of interest is the compound's pharmacokinetic properties. Recent preclinical studies have evaluated its bioavailability, metabolic stability, and toxicity profile. Results indicate that the dihydrochloride salt form enhances solubility and improves oral bioavailability, making it a more viable candidate for further drug development. However, challenges remain in optimizing its metabolic stability to reduce potential off-target effects.

Looking ahead, researchers are exploring the potential of {4-(5-Methyl-4H-1,2,4-triazol-3-yl)methylphenyl}amine Dihydrochloride in combination therapies. Preliminary data suggest synergistic effects when used alongside existing chemotherapeutic agents, offering a promising avenue for enhancing treatment efficacy. Further studies are needed to validate these findings and assess the compound's safety profile in clinical settings.

In conclusion, {4-(5-Methyl-4H-1,2,4-triazol-3-yl)methylphenyl}amine Dihydrochloride (CAS: 1185543-38-7) represents a versatile and promising compound in the realm of chemical biology and pharmaceutical research. Its unique structural properties and biological activities make it a valuable candidate for further investigation, with potential applications in oncology, inflammation, and beyond. Continued research efforts will be essential to fully unlock its therapeutic potential and translate these findings into clinical benefits.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)